AU6285194A - Stabilised pharmaceutical compositions and methods for preparing same - Google Patents

Stabilised pharmaceutical compositions and methods for preparing same

Info

Publication number
AU6285194A
AU6285194A AU62851/94A AU6285194A AU6285194A AU 6285194 A AU6285194 A AU 6285194A AU 62851/94 A AU62851/94 A AU 62851/94A AU 6285194 A AU6285194 A AU 6285194A AU 6285194 A AU6285194 A AU 6285194A
Authority
AU
Australia
Prior art keywords
methods
pharmaceutical compositions
preparing same
stabilised pharmaceutical
stabilised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62851/94A
Inventor
Radu Crainic
Karl Simpson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of AU6285194A publication Critical patent/AU6285194A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU62851/94A 1993-03-17 1994-03-17 Stabilised pharmaceutical compositions and methods for preparing same Abandoned AU6285194A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9303060A FR2702660B1 (en) 1993-03-17 1993-03-17 Stabilized therapeutic compositions and process for their preparation.
FR9303060 1993-03-17
PCT/FR1994/000296 WO1994021298A1 (en) 1993-03-17 1994-03-17 Stabilised pharmaceutical compositions and methods for preparing same

Publications (1)

Publication Number Publication Date
AU6285194A true AU6285194A (en) 1994-10-11

Family

ID=9445053

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62851/94A Abandoned AU6285194A (en) 1993-03-17 1994-03-17 Stabilised pharmaceutical compositions and methods for preparing same

Country Status (6)

Country Link
EP (1) EP0689457A1 (en)
CN (1) CN1119414A (en)
AU (1) AU6285194A (en)
CA (1) CA2158140A1 (en)
FR (1) FR2702660B1 (en)
WO (1) WO1994021298A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2293100A (en) * 1994-09-15 1996-03-20 Medeva Europ Ltd Pharmaceutical compositions with deuterium oxide
WO2003018614A1 (en) * 2001-08-24 2003-03-06 Wako Pure Chemical Industries, Ltd. Method of stabilizing substance altering in aqueous medium
US8734525B2 (en) 2003-12-31 2014-05-27 Warsaw Orthopedic, Inc. Osteoinductive demineralized cancellous bone
EP1701729B1 (en) 2003-12-31 2018-05-02 Warsaw Orthopedic, Inc. Improved bone matrix compositions and methods
JP2007519496A (en) * 2004-01-27 2007-07-19 オステオテック,インコーポレイテッド Stabilized bone graft
WO2007053850A2 (en) 2005-11-01 2007-05-10 Osteotech, Inc. Bone matrix compositions and methods
WO2008157495A2 (en) 2007-06-15 2008-12-24 Osteotech, Inc. Bone matrix compositions and methods
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
US9358113B2 (en) 2007-07-10 2016-06-07 Warsaw Orthopedic, Inc. Delivery system
US9101475B2 (en) 2009-02-12 2015-08-11 Warsaw Orthopedic, Inc. Segmented delivery system
FR2960781B1 (en) 2010-06-07 2013-11-22 Sanofi Pasteur PREPARATION OF STABILIZED DRY ORAL VACCINE COMPOSED OF ATTENUATED LIVE VIRUS
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
WO2016196367A1 (en) 2015-05-29 2016-12-08 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
MA51060A (en) 2017-12-07 2021-03-17 Merck Sharp & Dohme DENGUE VIRUS VACCINE COMPOSITION FORMULATIONS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability

Also Published As

Publication number Publication date
EP0689457A1 (en) 1996-01-03
WO1994021298A1 (en) 1994-09-29
CA2158140A1 (en) 1994-09-29
FR2702660A1 (en) 1994-09-23
FR2702660B1 (en) 1995-05-24
CN1119414A (en) 1996-03-27

Similar Documents

Publication Publication Date Title
AU4534593A (en) Compositions and methods for enhanced drug delivery
AU5681294A (en) Tastemasked pharmaceutical materials
AU2157192A (en) 4-aminoquinolines and pharmaceutical compositions thereof
AU2087992A (en) Pharmaceutical combination formulation
IL110376A0 (en) Pharmaceutical compositions containing ifetroban and methods for the preparation thereof
AU7707194A (en) Azole derivative and pharmaceutical composition thereof
AU6418596A (en) Compounds and pharmaceutical compositions containing them
AU3716193A (en) Pharmaceutical compositions
AU6285194A (en) Stabilised pharmaceutical compositions and methods for preparing same
AU5100393A (en) Diindolo compounds and pharmaceutical compositions containing them
AU3635693A (en) 1,4-dialkylpiperazine derivatives, method for obtaining them and pharmaceutical compositions containing them
AU5643894A (en) Novel esculetin derivatives and pharmaceutical composition
AU7275894A (en) Imidazolylalkylamine derivative and pharmaceutical composition thereof
AU2392492A (en) Pharmaceutical composition
AU5847694A (en) Chlorofluoroether compositions and preparation thereof
AU6690394A (en) Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof
IL119603A0 (en) Amidinohydrazone derivatives methods for the preparation thereof and pharmaceutical compositions containing the same
AU4756693A (en) 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
AU2493792A (en) Pharmaceutical preparation
AU3710695A (en) Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
AU6012990A (en) Pharmaceutical formulation
AU7318994A (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
AU4504893A (en) Novel 10-diacetyl baccatine iii derivatives, preparation thereof and pharmaceutical compositions containing them
AU2537992A (en) Pharmaceutical compositions
AU1482292A (en) Pharmaceutical composition and process for the preparation thereof